About
Continuing Education
Program
Register
Hotel and Parking Information
Education On Demand Program
Sponsorship
Next Gen Banner 960x180

Next Generation Migraine Therapies – Chicago

Sep172022

The Next Generation Migraine Therapies (NGMT) initiative is a comprehensive program designed to provide a multi-faceted approach to migraine education offered at no cost to healthcare providers. Brought to you by the American Headache Society, the program covers diagnosis and treatment of migraine and updates on the latest science.

Book Now
Next Gen Banner 960x180

Next Generation Migraine Therapies – Chicago

Sep172022

WHO SHOULD ATTEND

This program is designed for neurologists, family practitioners, internists and other health professionals who would like more information on the proper diagnosis and treatment of chronic migraine patients.

PURPOSE/OBJECTIVE

At the conclusion of this activity, attendees should be better able to:

  • Recognize the prevalence and epidemiology of migraine and unmet needs on current treatments
  • Discuss insights from basic science that underlie the next generation of migraine therapeutics
  • Utilize calcitonin gene-related peptide (CGRP)-targeted therapies in migraine prevention
  • Individualize and optimize migraine treatment using current and emerging therapeutic options

ACCREDITATION STATEMENT
The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

The American Headache Society® designates this Live Activity for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For those who register and participate in the Education On Demand program:

The American Headache Society® designates this Enduring Material for a maximum of 2.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For those who register and attend a live Q&A session after viewing the enduring material:

The American Headache Society® designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INSTRUCTIONS FOR CLAIMING CME

  • Attend sessions for which credit is sought in full (this includes watching on-demand courses).
  • Complete the post-activity evaluation.
  • A certificate of completion will be available once the evaluation is submitted.

FINANCIAL DISCLOSURES

The planners and faculty for this activity did not have any relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.

DISCLOSURE OF COMMERICAL SUPPORT

AbbVie Inc.
Lilly USA, LLC

Book Now
Next Gen Banner 960x180

Next Generation Migraine Therapies – Chicago

Sep172022

 

Next Generation Migraine Therapies

September 17, 2022 | Chicago, IL

Hyatt Regency O’Hare Chicago | International A/B/C

7:00 am – 7:45 am Course Registration and Continental Breakfast
7:45 am – 8:00 am Introduction, Program Overview and Pre-test

Michael Marmura, MD, FAHS

8:00 am – 9:00 am                           Overview of Migraine
8:00 am – 8:20 am Migraine: Making the Diagnosis

Michael Marmura, MD, FAHS

8:20 am – 8:45 am How Do I Explain Migraine to My Patients?

Michael Marmura, MD, FAHS

8:45 am – 9:00 am Q&A
9:00 am – 10:15 am Next Generation Acute Treatment: Addressing Unmet Needs
9:00 am – 9:30 am Overview of Acute Treatment and Best Practices in Migraine

Deborah Friedman, MD, MPH, FAHS

9:30 am – 10:00 am Advances in Acute Therapies for Migraine and How to Integrate Them Into Your Practice: New Formulations, Ditans and Gepants

Deborah Friedman, MD, MPH, FAHS

10:00 am – 10:15 am Q&A
10:15 am – 10:30 am Break
10:30 am – 12:00 pm Next Generation Preventive Treatment
10:30 am – 10:45 am How Do We Approach Preventive Migraine Treatment?

Larry Charleston, IV, MD, MS, FAHS

10:45 am – 11:10 am Monoclonal Antibodies Targeting CGRP and Gepants

Speaker TBD

11:10 am – 11:30 am Behavioral Treatments for Migraine

Scott Powers, PhD, CCH, FAHS

11:30 am – 11:50 am Updates in Pediatric Migraine

Rashmi Rao, MD

11:50 am – 12:00 pm Q&A
12:00 pm – 1:15 pm Working Lunch: Case Discussions

Moderator: Michael Marmura, MD, FAHS (Claire Sandoe, MD)

1:15 pm – 1:30 pm Break
1:30 pm – 3:45 pm Procedures, Devices and Non-pharmacological Treatment Workshops

Attendees will be broken into two (2) groups. Each group will be assigned a workshop initially and then switch to the other at the break allowing attendees to attend both workshops. Workshop assignment is noted on the back of the attendee name badge.

1:30 pm – 2:30 pm Workshop 1: Procedures
1:30 pm – 2:00 pm OnabotulinumtoxinA: Nerve Blocks and Other Procedures for Migraine

Deborah Friedman, MD, MPH, FAHS

2:00 pm – 2:30 pm Headache Procedures: Hands-on Training

Larry Charleston, IV, MD, MS, FAHS and Deborah Friedman, MD, MPH, FAHS

1:30 pm – 2:30 pm Workshop 2: Nonpharmacologic Treatments
1:30 pm – 2:00 pm Behavioral Enhancements to Migraine Management

Scott Powers, PhD, CCH, FAHS

2:00 pm – 2:30 pm Neuromodulation for Migraine: Current and Future Devices

Speaker TBD

2:30 pm – 2:45 pm Break (attendees switch rooms-workshops repeat)
2:45 pm – 3:45 pm Workshop 1: Procedures
2:45 pm – 3:15 pm  OnabotulinumtoxinA: Nerve Blocks and Other Procedures for Migraine

Deborah Friedman, MD, MPH, FAHS

3:15 pm – 3:45 pm Headache Procedures: Hands-on Training

Larry Charleston, IV, MD, MS, FAHS and Deborah Friedman, MD, MPH, FAHS

2:45 pm – 3:45 pm Workshop 2: Nonpharmacologic Treatments
2:45 pm – 3:15 pm Behavioral Enhancements to Migraine Management

Scott Powers, PhD, CCH, FAHS

3:15 pm – 3:45 pm Neuromodulation for Migraine: Current and Future Devices

Speaker TBD

3:45 pm Closing Remarks and Post-Test

Michael Marmura, MD, FAHS

 

Book Now
Next Gen Banner 960x180

Next Generation Migraine Therapies – Chicago

Sep172022

Online registration is now open. To register at no cost, click here.

Book Now
Next Gen Banner 960x180

Next Generation Migraine Therapies – Chicago

Sep172022

Conference Hotel
Hyatt Regency O’Hare Chicago
9300 Bryn Mawr Ave.
Rosemont, IL 60018
1-847-696-1234

As the largest hotel outside the city, Hyatt Regency O’Hare Chicago is home to spaces ranging from traditional ballrooms to inspiring networking areas, and top-floor reception venues. Located five minutes from O’Hare International Airport, and offering a complimentary airport shuttle, we are a comfortable and convenient location for travelers.

AHS has booked a block of hotel rooms for attendees who want to spend the night. The group rate is $169/night (+tax). The group rate expires on August 26 or when the block sells out (whichever comes first). Please book early to secure your room at the group rate. Book using this link.

PARKING
If you drive to the workshop, we have a discounted parking rate at the Hyatt Regency of $16/day (with in and out privileges).

Book Now
Next Gen Banner 960x180

Next Generation Migraine Therapies – Chicago

Sep172022

Unable to attend Next Generation Migraine Therapies in-person? Register for the Education On Demand program to view past NGMT content for up to 2.75 AMA PRA Category 1 Credits™

Pre-recorded Lectures Available On Demand
Introduction and Program Overview
Kathleen B. Digre, MD, FAHS
Migraine Diagnosis, Epidemiology, and Pathophysiology
Kathleen B. Digre, MD, FAHS
What’s New in Acute Migraine Treatment
Stewart J. Tepper, MD, FAHS
Behavioral Approaches in Migraine Management
Dawn C. Buse, PhD, FAHS
What’s New in Migraine Prevention
Michael Marmura, MD, FAHS
Book Now
Next Gen Banner 960x180

Next Generation Migraine Therapies – Chicago

Sep172022

AHS gratefully acknowledges sponsorship of the 2022 Next Generation Migraine Therapies Program from our industry supporters:

BRONZE

 

AHS gratefully acknowledges educational grant support of the 2022 Next Generation Migraine Therapies Program from our industry supporters:

AbbVie Inc.
Lilly USA, LLC

 

Book Now